You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中基長壽科學(00767.HK)擬收購東展醫藥51%股權
格隆匯 08-13 21:45

格隆匯8月13日丨中基長壽科學(00767.HK)公吿,於2021年8月13日,公司與東展醫藥唯一股東吳錦棠訂立股權收購框架協議,據此,公司擬向吳錦棠收購東展醫藥51%股權。 

雙方同意委託獨立的評估機構,對東展醫藥作出專業評核,公司將參照評估報吿,向吳提出合理的價錢收購東展醫藥股權,令公司立即獲得疫苗、抗生素批發銷售合法經營權。公司在完成潛在收購後,將委任新董事及管理層到東展醫藥,並組建與整合公司現有的生物製劑營銷管理團隊,建立全球特別是大中華區的疫苗、抗生素、長壽生物製劑等批發銷售網絡,為構建人類命運共同體做貢獻。

東展醫藥是一間2016年成立的業務遍及全球的醫藥批發公司,擁有藥劑業及毒藥條例第138章批發商牌照和經營抗生素條例第137章適用的物質和製劑的許可證,擁有持牌合法經營疫苗方面的優勢。

董事會相信潛在收購可進一步完善集團全球長壽科學領域的佈局,進一步提升集團在長壽醫學產業鏈的領先地位,長遠為集團帶來穩定、持續增長收入。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account